C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/40 (2006.01) A61K 31/44 (2006.01) A61K 31/47 (2006.01) A61K 31/4709 (2006.01) A61K 31/4725 (2006.01) A61P 43/00 (2006.01) C07D 215/38 (2006.01) C07D 401/12 (2006.01)
Patent
CA 2443950
This invention relates to a group of quinolyl, isoquinolyl and pyridyl ureas, their use in treating raf mediated diseases, and pharmaceutical compositions which contain these ureas for use in such therapy. These compounds have one of the following formulae: A D B (I) A'-D-B' (II) A"~D~B" (III) wherein D is -NH-C (O)-NH-; A is a substituted pyridyl group; A' is an optionally substituted isoquinolinyl group or a quinolinyl group; A" is a substituted quinolinyl group, B and B' are each, independently, a substituted or unsubstituted bridged cyclic structure of up to 30 carbon atoms; and a cyclic moiety having at least 5 members and B" is a substituted or unsubstituted, up to tricyclic aryl or heteroaryl moiety of up to 30 carbon atoms.
La présente invention concerne un groupe d'urées de quinolyl, d'isoquinolyl et de pyridyl, leur utilisation dans le traitement de maladies induites par raf, ainsi que des compositions pharmaceutiques renfermant ces urées, destinées à être utilisées dans de telles thérapies.
Dumas Jacques
Gunn David E.
Hatoum-Mokdad Holia
Khire Uday
Lowinger Timothy B.
Bayer Healthcare Llc
Corporation Bayer
Smart & Biggar
LandOfFree
Inhibition of raf kinase using quinolyl, isoquinolyl or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of raf kinase using quinolyl, isoquinolyl or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of raf kinase using quinolyl, isoquinolyl or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1859086